Using Bioinformatics to Identify Novel Druggable Targets for Retinal Neovascularisation Causing Loss of Vision: Transforming Growth Factor Beta-Activated Kinase 1 (TAK1)
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.